Pharmaceutical Industry Reports Poly Adenosine Diphosphate Ribose Polymerase Marke | Page 2

REPORT DESCRIPTION
Poly Adenosine Diphosphate Ribose Polymerase Market – Overview
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several
(poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in
restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some
anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme
important for the repair of single stranded breaks in DNA that effectively destroys cancer cells.
These inhibitors play an effective role in current cancer-combating strategies, owing to its effectiveness in
eliminating cancer cells as compared to the existing ovarian cancer treatments. Drugs such as Talazoparib
and Veliparib that aid in treatment of ovarian cancer are in phase III clinical trials. Such research and
development activities is a key factor contributing to the global poly adenosine diphosphate ribose
polymerase market growth.
High prevalence of various types of cancer is a key factor contributing to growth of the global poly
adenosine diphosphate ribose polymerase market. Cancer is one of the most prevalent fatal chronic
disorders with a high mortality rate due to its invasive nature and prolonged duration of disease.
© Coherent market Insights. All Rights Reserved